UnitedHealth Group (NYSE:UNH) Trading Up 2% – Here’s Why

UnitedHealth Group Incorporated (NYSE:UNH) shares traded up 2% during mid-day trading on Thursday . The company traded as high as $354.95 and last traded at $354.74. 7,361,077 shares traded hands during mid-day trading, an increase of 5% from the average session volume of 7,010,502 shares. The stock had previously closed at $347.75.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Mizuho Securities reiterated a Buy on UNH with a $430 price target and flagged the upcoming Medicare Advantage 2027 advance notice as a potential catalyst. Mizuho Securities Remains Positive on UnitedHealth Group Amid the Upcoming Medicare Advantage 2027 Advance Notice
• Neutral Sentiment: Analyst previews and model checks are being circulated ahead of Q4 results and Jan. 27 — investors are watching metrics beyond revenue/EPS (medical cost trend, MCR, membership mix). Countdown to UnitedHealth (UNH) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
• Neutral Sentiment: Market commentary reminds investors to note Jan. 27 as the date for clarity on Q4 results and forward guidance; that timing is driving positioning. Dear UnitedHealth Stock Fans, Mark Your Calendars for January 27
• Negative Sentiment: UnitedHealth told Congress it will rebate 2026 ACA plan profits to members — positive for consumers but likely a near-term hit to profits and guidance sensitivity. UnitedHealth to offer rebates to its Obamacare customers
• Negative Sentiment: UnitedHealth and other insurer CEOs faced congressional questioning on affordability — increased regulatory/political scrutiny raises execution and PR risk. UnitedHealth and CVS Get Grilled on Affordability by Congress
• Negative Sentiment: Analysts warn that rising medical costs and a higher medical cost ratio (MCR) could compress margins; some outlets advise waiting until Jan. 27 (earnings/advance-notice) before adding to positions. Buying UnitedHealth Before Q4 Earnings? Cost Pressures a Red Flag
• Negative Sentiment: High-profile media takes (e.g., Jim Cramer) are favoring peers like CVS over UNH, which can influence retail flows and sentiment near this catalyst window. Jim Cramer Says “Let’s Buy CVS, Not UnitedHealth”

Analysts Set New Price Targets

Several equities research analysts have recently commented on UNH shares. Mizuho boosted their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. UBS Group lifted their target price on shares of UnitedHealth Group from $378.00 to $430.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Jefferies Financial Group raised their price target on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a report on Friday, October 17th. Finally, Sanford C. Bernstein increased their target price on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.75.

UnitedHealth Group Stock Up 2.0%

The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm has a 50-day simple moving average of $330.93 and a two-hundred day simple moving average of $322.74. The stock has a market cap of $321.34 billion, a P/E ratio of 18.51, a PEG ratio of 2.04 and a beta of 0.42.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period last year, the firm earned $7.15 earnings per share. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, December 8th. UnitedHealth Group’s payout ratio is 46.14%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Capital World Investors lifted its position in shares of UnitedHealth Group by 18.8% during the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock worth $7,516,107,000 after buying an additional 3,439,182 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 3.3% in the second quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock worth $6,624,411,000 after acquiring an additional 675,075 shares during the last quarter. Capital International Investors grew its holdings in shares of UnitedHealth Group by 11.1% during the 3rd quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate’s stock valued at $6,042,710,000 after purchasing an additional 1,747,337 shares during the last quarter. Capital Research Global Investors boosted its position in UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock valued at $4,503,419,000 after buying an additional 7,293,009 shares in the last quarter. Finally, Norges Bank bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at $3,837,207,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.